New cells are often produced in the body during growth and development. In addition, new cells also develop as the body repairs and remodels its tissues after an injury. These new cells come from mesenchymal stem cells (MSCs), which are considered as multipotent cells. MSCs are found in various parts of the body during growth and development, but in adults, they are present in the bone marrow, where they later differentiate, mature and migrate to become more specialized cells with unique functions. These cells' potential to develop into bone cells, cartilage cells, muscle cells and fat cells makes their role in regeneration, repair and remodelling important, especially when the body undergoes the normal process of aging or recovers from disease or injury.
Research shows, however, that the potential of stem cells to proliferate and mature into specialized cells may be hindered by compounds known as advanced glycation end-products (AGEs). These compounds are formed by a chemical reaction called glycation, which involves attaching sugar molecules to proteins without the use of enzymes. This process initiates a complex series of molecular rearrangements and dehydrations that produces cross-linked proteins, resulting in the disruption of normal metabolic processes.
Glycation and AGEs
The body normally metabolizes substances such as simple sugars and proteins to produce energy, build tissues and many more functions. In the molecular level, chemical reactions such as glycosylation occur, in which a carbohydrate molecule attaches to another protein molecule to form another substance. These chemical reactions are often catalyzed by enzymes resulting in the formation of various glycans, which are involved in many structural and ...
... middle of paper ...
...
Kume , Kato S, Yamagishi S, Inagaki, Y, et al. Advanced Glycation End-Products Attenuate Human Mesenchymal Stem Cells and Prevent Cognate Differentiation Into Adipose Tissue, Cartilage, and Bone. J Bone Miner Res, 2005. 20: 1647–1658. doi: 10.1359/JBMR.050514
Yang K, Wang XQ, He YS, et al. Advanced glycation end products induce chemokine/cytokine production via activation of p38 pathway and inhibit proliferation and migration of bone marrow mesenchymal stem cells. Cardiovasc Diabetol, 2010, 9:66.
Toth C, Rong L, Yang C, et al. Receptor for Advanced Glycation End Products (RAGEs) and Experimental Diabetic Neuropathy
Diabetes. 2008;57(4):1002-1017.
Hu X, Cheng Y. Possible participation of receptor for advanced glycation end products (RAGE) in the origin of cancer stem cells in diabetic patients with colon cancer. Med Hypotheses. 2013 May;80(5):620-3.
Intramembranous ossification is the process in which the flat bones of the cranium ad clavicles are made. This type of ossification is broken up into several different steps. In each of these steps, there are various types of cells that do unique things to aid in ossification. All of these different cells stem from one cell known as a Mesenchymal cell. This cell is a type of stem cell that can differentiate into all of the different connective tissue cells. Differentiation is a characteristic of these cells that allows them to transform into various cells during the growth process; this is aided by methylation. Methylation aids differentiation because it shuts down specific genes in the cells DNA which changes the shape and function and
Stem cells are the building blocks of the human body. Embryos consist of unspecialized stem cells that transform into the various specialized cells in the body such as cardiac, muscle or bone cells. Fetuses also have stem cells. However, the stem cells are divided into types like muscle, bone or nerves and don't perform a specialized function. Surprisingly, adult bodies also contain stem cells. In adults, stem cells are undifferentiated but limited to specific tissue type. When needed, the stem cells transform into the cells needed for repair and maintenance. The most common source of adult stem cells is bone marrow. Researchers also acquire stem cells from umbilical cords. Without stem cells, embryos could not develop into fetuses and adult
The wide range of prospective uses for stem cells could greatly improve the health and wellbeing of many people. In stem cell treatments, undifferentiated cells are programmed to form specific cells, which can then be transplanted to the afflicted area. Stems cells can possibly treat afflictions including “Alzheimer’s diseases, spinal cord injury, stroke, burns, heart disease, diabetes, osteoarthritis, and rheumatoid arthritis” (“Stem Cell Basics”). Another important use is in drug testing. Drugs can be tested on stem cells that develop into the target tissue before using it on human test subjects, which improves safety. Finally, transplantation of organs created from stem cells could eliminate the need for human...
Background and objective. Tumor heterogeneity is shown to be related to clinical outcome in cancer patients. The concept of a small subset of cancer stem cells being responsible for tumor relapse and metastasis comes out as a promising strategy for targeted cancer therapy. However, cancer stem cells are not easy to identify and isolate. The aim of this study was to determine the putative colon cancer stem cell subsets in human colon cancer cell lines HCT116 and HT29, which differ in their aggressiveness and differentiation capacity. Material and methods. Flow cytometry was used to asses HCT116 and HT29 cell lines for the expression of stemness-associated surface markers CD24, CD44, CD117, CD133, ESA, ABCB1. Both cell lines were treated with 5-fluoruracil and the phenotype of chemoresistant cells was investigated. Side population was visualized via Rhodamine 123 staining. Relative expression of ABCG2, c-Myc and Oct4 genes was quantified using qPCR analysis. Results and conclusions. It was shown that HCT116 and HT29 cell lines differ in their stemness-related properties. We imply that putative CSC subset for HCT116 cell line is CD44+/CD24-/CD133- (4,1% of all cells) and for HT29 cells – CD24+/CD44-/CD133- (4,9% of all cells).
6. Claiborn K, Stoffers D. Toward a cell-based cure for diabetes: advances in production and transplant of beta cells. The Mount Sinai Journal Of Medicine, New York [serial online]. August 2008;75(4):362-371. Available from: MEDLINE with Full Text, Ipswich, MA. Accessed November 19, 2013.
Stem cell research began in 1956 when Dr. E Donnall Thomas performed the first bone marrow transplant (“Adult stem cells are not more promising,” 2007). Since that time, research has evolved into obtaining cells from a variety of tissues. According to stem cell research professors, Ariff Bongso and Eng Hin Lee (2005), “Stem cells are unspecialized cells in the human body that are capable of becoming cells, each with new specialized functions” (p. 2). Stem cells are in various adult tissues, such as bone marrow, the liver, the epidermis layer of skin, the central nervous system, and eyes. They are also in other sources, such as fetuses, umbilical cords, placentas, embryos, and induced pluripotent stem cells (iPSCs), which are cells from adult tissues that have been reprogrammed to pluripotency. Most stem cells offer multipotent cells, which are sparse...
Stem cells are a type of unspecialized cells that can revive themselves through the process of cell division (Abdel-Salam and Oma, 2011). They have a phenomenal potential to differentiate into other specific cell types in a living organism. These cells can also be activated to turn into organ-specific cells or tissues with defined activity but only under specific experimental set-up. Stem cells have the ability to remain as they are or divide further to renew deteriorated and damaged tissue cells. Recently it has been discovered that stem cells can be used to treat Alzheimer’s disease, but still a lot of clinical trials are being conducted to find a specific government approved treatment.
Collison, Kate S, et al. “Prediabetic changes in gene expression induced by aspartame and monosodium glutamate in trans fat-fed C5731/6J mice.” Nutr Metab (Lond). 2013. PubMed Central. Web. 18 November 2013.
Li, Y., Wicha, M. S., Schwartz, S. J., & Sun, D. (2011, February 4). Implications of Cancer Stem Cell Theory for Cancer Chemoprevention by Natural Dietary Compounds. Retrieved December 12, 2013, from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248810/
“Stem Cells: The Future of Medicine.” Medschool.umaryland.edu. University of Maryland School of Medicine Web 14 Nov 2013
Our body needs energy to carry out its functions properly. This energy is synthesized from the food we eat. Our body breaks down the food we take in and then build up the required materials for a healthy functioning of our body. Glucose, a simple sugar or monosaccharide that is the end product of carbohydrate digestion, is a primary source of energy for living things. (Taber’s, 2005). Glucose gets absorbed from our intestines and distributed by the bloodstream to all of the cells in our body. If the supply of glucose is more than required, our body stores the excess amount of glucose as glycogen, a chain of glucose. If there is shortage in other hand, our body uses the stored...
Diabetic Neuropathy is a group of neurological disorders caused by nerve damage resulting from the effects of type one and type two diabetes. There are several types of neurological diseases, each affecting the individual differently. Each disorder presents with its own symptoms, prognosis, and risks. It is important for the diabetic patient to receive adequate education from their physician on the basic signs and symptoms of neuropathy. Early identification and frequent check-ups can greatly impact the effects of neuropathy.
Carbohydrates that are consumed by a diabetic will have the most effect on his or her blood glucose levels (Watts & Anselmo, 2006, p. 46). Because of this, carbohydrates play an important role in th...
damaged tissues. The emerging use of stem cell research is a relatively new concept. Due to the
Researchers in this field are seek to know how stem cells can be used to develop into specialized cells or tissue, which aims restore lost function in damaged organs or even grow new fully functioning organs for transplant.